Chumakov K - Search Results

1

A novel gamma radiation-inactivated sabin-based polio vaccine.

Tobin GJ, Tobin JK, Gaidamakova EK, Wiggins TJ, Bushnell RV, Lee WM, Matrosova VY, Dollery SJ, Meeks HN, Kouiavskaia D, Chumakov K, Daly MJ. Tobin GJ, et al. Among authors: chumakov k. PLoS One. 2020 Jan 30;15(1):e0228006. doi: 10.1371/journal.pone.0228006. eCollection 2020. PLoS One. 2020. PMID: 31999745 Free PMC article.

2

Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.

Dragunsky EM, Ivanov AP, Wells VR, Ivshina AV, Rezapkin GV, Abe S, Potapova SG, Enterline JC, Hashizume S, Chumakov KM. Dragunsky EM, et al. J Infect Dis. 2004 Oct 15;190(8):1404-12. doi: 10.1086/424524. Epub 2004 Sep 20. J Infect Dis. 2004. PMID: 15378432

3

Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV).

Rezapkin G, Dragunsky E, Chumakov K. Rezapkin G, et al. Among authors: chumakov k. Biologicals. 2005 Mar;33(1):17-27. doi: 10.1016/j.biologicals.2004.11.003. Biologicals. 2005. PMID: 15713553

4

Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method.

Rezapkin G, Martin J, Chumakov K. Rezapkin G, et al. Among authors: chumakov k. Biologicals. 2005 Mar;33(1):29-39. doi: 10.1016/j.biologicals.2004.11.001. Epub 2005 Jan 27. Biologicals. 2005. PMID: 15713554

5

Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains.

Laassri M, Lottenbach K, Belshe R, Wolff M, Rennels M, Plotkin S, Chumakov K. Laassri M, et al. Among authors: chumakov k. J Infect Dis. 2005 Dec 15;192(12):2092-8. doi: 10.1086/498172. Epub 2005 Nov 8. J Infect Dis. 2005. PMID: 16288372 Clinical Trial.

6

1,25-dihydroxyvitamin d3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice.

Ivanov AP, Dragunsky EM, Chumakov KM. Ivanov AP, et al. J Infect Dis. 2006 Feb 15;193(4):598-600. doi: 10.1086/499970. Epub 2006 Jan 12. J Infect Dis. 2006. PMID: 16425140

7

Further development of a new transgenic mouse test for the evaluation of the immunogenicity and protective properties of inactivated poliovirus vaccine.

Dragunsky EM, Ivanov AP, Abe S, Potapova SG, Enterline JC, Hashizume S, Chumakov KM. Dragunsky EM, et al. J Infect Dis. 2006 Sep 15;194(6):804-7. doi: 10.1086/506949. Epub 2006 Aug 16. J Infect Dis. 2006. PMID: 16941347

8

Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.

Asturias EJ, Dueger EL, Omer SB, Melville A, Nates SV, Laassri M, Chumakov K, Halsey NA. Asturias EJ, et al. Among authors: chumakov k. J Infect Dis. 2007 Sep 1;196(5):692-8. doi: 10.1086/520546. Epub 2007 Jul 23. J Infect Dis. 2007. PMID: 17674310 Clinical Trial.

9

New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis.

Chumakov K, Ehrenfeld E. Chumakov K, et al. Clin Infect Dis. 2008 Dec 15;47(12):1587-92. doi: 10.1086/593310. Clin Infect Dis. 2008. PMID: 18990066 Free PMC article. Review.

10

Repertoire of antibodies against type 1 poliovirus in human sera.

Rezapkin G, Neverov A, Cherkasova E, Vidor E, Sarafanov A, Kouiavskaia D, Dragunsky E, Chumakov K. Rezapkin G, et al. Among authors: chumakov k. J Virol Methods. 2010 Nov;169(2):322-31. doi: 10.1016/j.jviromet.2010.07.037. Epub 2010 Aug 4. J Virol Methods. 2010. PMID: 20691212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page